Dynocardia, Inc.
PrivateLast Round
Grant
Dec 11, 2024
Total Funding Raised
$7.76M
Company Overview
Dynocardia, Inc. is a healthtech company that develops ViTrack, a wearable, cuff-less device for continuous and non-invasive blood pressure monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Computer Vision
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
cuff-less blood pressurecontinuous blood pressurewearable medical devicemedtechcritical care monitoringcNIBPbeat-to-beat blood pressurehemodynamic monitoringremote patient monitoringRPMhypertension managementwearable health techvital signs monitoringoptomechanical sensorcomputer vision
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dynocardia, Inc. Comps
Public and private peers based on sector, stage, and business model.
Dynocardia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2024 | ||||
| Grant | Oct 10, 2024 | ||||
| Grant | Feb 20, 2024 | ||||
| Series A | Mar 24, 2023 | ||||
| Grant | Mar 1, 2022 | ||||
Seed | Jan 31, 2020 |
Dynocardia, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Dynocardia, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dynocardia, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersCambridge, Massachusetts
Employee Range16
Year Founded2018
Last FundingDec 11, 2024
